Turmeric in the Management of Oral Submucous Fibrosis - A Systematic Review and Meta-analysis

Overview

Journal Int J Health Sci (Qassim)

Specialty General Medicine

Date 2020 Jun 16

PMID 32536848

Citations 6

Authors

Ekta Ingle

Affiliations

Soon will be listed here.

Abstract

Objectives: Oral submucous fibrosis (OSMF), a premalignant condition, is frequently occur in the buccal mucosa and is associated with betel nut chewing. Various treatment modalities are tested to treat this condition. An effective intervention is needed, which is cost effective, safe, and efficient, considering the disease burden in high incident countries. Turmeric has promising results in the management of OSMF because of its potent anti-inflammatory and anti-oxidant pharmacological actions. The objectives of the study were to analyze the efficacy of turmeric in managing OSMF based on the available literature.

Methods: The articles were searched from Medline/PubMed and Journal of web, which were published from 2000 to 2019 and reviewed for the determined outcomes.

Results: The review showed a positive response for turmeric usage in managing OSMF, in terms of improved mouth opening and decreased burning sensation.

Conclusion: Multicenter studies in high incidence countries with long-term follow-up are recommended to better understand the curative aspect of curcumin in OSMF.

Citing Articles

Effect of turmeric and triphala in the treatment of oral submucous fibrosis among Indians.

Singh P, Gaur B, Banu S, M P, Rahangadale T, Gupta R Bioinformation. 2024; 20(8):851-854.

PMID: 39411770 PMC: 11471418. DOI: 10.6026/973206300200851.

Efficacy of topical in the healing of extraction sockets: A split-mouth clinical trial.

Pandya K, Abbinayah D, Selvakumar D, Jayakumar N Dent Res J (Isfahan). 2023; 20:110.

PMID: 38020260 PMC: 10680070.

Differential expression of cancer stem cell markers and pro-inflammatory cytokine IL-1β in the oral squamous cell carcinoma and oral submucosal fibrosis.

Awasthi S, Ahmad S, Gupta R, Iqbal M, Ahmad A Int J Health Sci (Qassim). 2023; 17(6):28-38.

PMID: 37929238 PMC: 10624801.

Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis.

Hanyu F, Zheng H, Jiaqi W, Tairan D, Yiyuanzi Z, Qiwen Y Front Pharmacol. 2023; 14:1258885.

PMID: 37900163 PMC: 10613035. DOI: 10.3389/fphar.2023.1258885.

Effects of turmeric (Curcuma longa) on oral health.

Umapathy V, Swamikannu B, Jones S, Kiran M, Lell T, Mayasa V Bioinformation. 2023; 18(6):538-542.

PMID: 37168791 PMC: 10165051. DOI: 10.6026/97320630018538.

References

Saran G, Umapathy D, Misra N, Ganiga Channaiah S, Singh P, Srivastava S . A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial. Indian J Dent Res. 2018; 29(3):303-312. DOI: 10.4103/ijdr.IJDR_551_16. View

Angadi P, Rekha K . Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians. Oral Maxillofac Surg. 2010; 15(1):15-9. DOI: 10.1007/s10006-010-0225-x. View

Vallianou N, Evangelopoulos A, Schizas N, Kazazis C . Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 2015; 35(2):645-51. View

Chang M, Chiang C, Lin C, Lee J, Hahn L, Jeng J . Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol. 2005; 41(8):757-75. DOI: 10.1016/j.oraloncology.2005.01.007. View

Tilakaratne W, Klinikowski M, Saku T, Peters T, Warnakulasuriya S . Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2005; 42(6):561-8. DOI: 10.1016/j.oraloncology.2005.08.005. View

Hazarey V, Sakrikar A, Ganvir S . Efficacy of curcumin in the treatment for oral submucous fibrosis - A randomized clinical trial. J Oral Maxillofac Pathol. 2015; 19(2):145-52. PMC: 4611920. DOI: 10.4103/0973-029X.164524. View

Piyush P, Mahajan A, Singh K, Ghosh S, Gupta S . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: A randomized controlled trial. Oral Dis. 2018; 25(1):73-79. DOI: 10.1111/odi.12947. View

Rajalalitha P, Vali S . Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder. J Oral Pathol Med. 2005; 34(6):321-8. DOI: 10.1111/j.1600-0714.2005.00325.x. View

Wang Y, Tail Y, Wang W, Chen C, Kao Y, Chen Y . Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health. 2014; 14:99. PMC: 4134123. DOI: 10.1186/1472-6831-14-99. View

10.

Joe B, Vijaykumar M, Lokesh B . Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004; 44(2):97-111. DOI: 10.1080/10408690490424702. View

11.

Kim Y, Ahn Y, Hong M, Joo S, Kim K, Sohn I . Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J Cardiovasc Pharmacol. 2007; 50(1):41-9. DOI: 10.1097/FJC.0b013e31805559b9. View

12.

Baum L, Ng A . Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimers Dis. 2004; 6(4):367-77. DOI: 10.3233/jad-2004-6403. View

13.

Warnakulasuriya S, Ariyawardana A . Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2015; 45(3):155-66. DOI: 10.1111/jop.12339. View

14.

Srivastava A, Agarwal R, Chaturvedi T, Chandra A, Singh O . Clinical evaluation of the role of tulsi and turmeric in the management of oral submucous fibrosis: A pilot, prospective observational study. J Ayurveda Integr Med. 2015; 6(1):45-9. PMC: 4395929. DOI: 10.4103/0975-9476.146563. View

15.

Haider S, Merchant A, Fikree F, Rahbar M . Clinical and functional staging of oral submucous fibrosis. Br J Oral Maxillofac Surg. 2000; 38(1):12-5. DOI: 10.1054/bjom.1999.0062. View

16.

SIRSAT S, Khanolkar V . Submucous fibrosis of the palate and pillars of the fauces. Indian J Med Sci. 1962; 16:189-97. View

17.

Cox S, Walker D . Oral submucous fibrosis. A review. Aust Dent J. 1996; 41(5):294-9. DOI: 10.1111/j.1834-7819.1996.tb03136.x. View

18.

Rai B, Kaur J, Jacobs R, Singh J . Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci. 2010; 52(2):251-6. DOI: 10.2334/josnusd.52.251. View

19.

Kerr A, Warnakulasuriya S, Mighell A, Dietrich T, Nasser M, Rimal J . A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis. 2011; 17 Suppl 1:42-57. DOI: 10.1111/j.1601-0825.2011.01791.x. View

20.

Wollina U, Verma S, Ali F, Patil K . Oral submucous fibrosis: an update. Clin Cosmet Investig Dermatol. 2015; 8:193-204. PMC: 4401336. DOI: 10.2147/CCID.S80576. View